Journals / Türk Biyokimya Dergisi / 2019 / Cilt: 44 - Sayı: 2

Association of oxidative stress marker ischemia modified albumin and polycystic ovary syndrome in adolescent and young girls

Adölesan ve genç kızlarda oksidatif stres belirteci iskemi modifiye albümin ve polikistik over sendromu arasındaki ilişki

Pages
161–169
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This elevation maycontribute to the increased cardiovascular diseases risk inPCOS patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The pathophysiologic features of polycystic ovary syndrome (PCOS) seem to be a combinationof genetic predisposition and environmental factors.However, data regarding the exact effect of oxidative stresson PCOS is conflicting.
📊
Key Findings & Data:This cross sectional and case-control study was designed to compare the serum ischemiamodified albumin (IMA) levels in adolescent and younggirls with and without PCOS.Methods: A total of 41 non-obese adolescents and younggirls (15–21 years) diagnosed as PCOS and 41 age andbody mass index (BMI) matched controls were enrolled tostudy.
💡
Conclusion & Impact:This elevation maycontribute to the increased cardiovascular diseases risk inPCOS patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The pathophysiologic features of polycystic ovary syndrome (PCOS) seem to be a combinationof genetic predisposition and environmental factors.However, data regarding the exact effect of oxidative stresson PCOS is conflicting. This cross sectional and case-control study was designed to compare the serum ischemiamodified albumin (IMA) levels in adolescent and younggirls with and without PCOS.Methods: A total of 41 non-obese adolescents and younggirls (15–21 years) diagnosed as PCOS and 41 age andbody mass index (BMI) matched controls were enrolled tostudy. The main features of PCOS and markers of chronicinflammation were determined together with serum IMAlevels at the time of study enrollment.Results: The C-reactive protein and neutrophil-to-lymphocyte ratio were within the normal ranges and also there wereno significant difference between the two groups (p > 0.05).Serum levels of IMA were significantly increased in adolescents with PCOS respect to healthy controls (0.44 ± 0.12versus 0.35 ± 0.10 absorbance units, p < 0.001). And alsothere was a significant positive correlation between serumIMA and BMI in all groups (r = 0.274, p = 0.013).Conclusion: Serum IMA levels were higher in PCOSpatients than in the healthy controls. This elevation maycontribute to the increased cardiovascular diseases risk inPCOS patients.

Özet

Amaç: Polikistik over sendromunun (PKOS) patofizyolojik özellikleri genetik yatkınlık ve çevresel faktörlerin bir kombinasyonu gibi görünmektedir. Bununla birlikte, oksidatif stresin PKOS üzerindeki net etkileri ile ilgili veriler çelişkilidir. Bu kesitsel ve vaka-kontrol çalışma, PKOS olan ve olmayan adölesan ve genç kızlarda serum iskemi modifiye albümin (İMA) seviyelerini karşılaştırmak için tasarlanmıştır. Metod: Çalışmaya PKOS tanısı alan toplam 41 obez olmayan adölesan ve genç kız (15–21 yaş) ile 41 yaş ve vücut kitle indeksi (VKİ) bakımından eşleştirilmiş sağlıklı kontrol dâhil edildi. Tüm katılımcılarda, çalışmaya kayıt sırasında, PKOS’un ana özellikleri ve kronik inflamasyon belirteçleri ile birlikte serum İMA seviyeleri belirlendi. Bulgular: C-reaktif protein ve nötrofil-lenfosit oranı her iki grupta normal sınırlardaydı ve gruplar arasında anlamlı fark yoktu (p > 0.05). Sağlıklı kontrollere göre PKOS’lu adölesanlarda serum İMA düzeyleri anlamlı olarak artmıştı (0.44 ± 0.12 ve 0.35 ± 0.10 absorbans birimi, p < 0.001). Ayrıca tüm grupta serum İMA ve VKİ arasında anlamlı pozitif korelasyon vardı (r = 0.274, p = 0.013). Sonuç: PKOS hastalarında serum İMA düzeyleri sağlıklı kontrollere göre daha yüksektir. Bu artış, PKOS hastalarında artmış kardiyovasküler hastalık riskine katkıda bulunabilir.

🔖

Cite This Article

AKSOY, R. T., TOKMAK, A., TURHAN, T., TAŞCI, Y., BODUR, S., KÖSEM, A., TOPÇUOĞLU, C. (2022). Association of oxidative stress marker ischemia modified albumin and polycystic ovary syndrome in adolescent and young girls. Türk Biyokimya Dergisi, Cilt: 44 - Sayı: 2, 161–169. https://ajindex.com/articles/620882

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulinsensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2009;13:CD003053
  2. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility, 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2011. Chronic anovulation and the polycystic ovary syndrome, 495–531
  3. Legro RS. Polycystic ovary syndrome. Long term sequelae and management. Minerva Ginecol 2002;54:97–114
  4. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012;33: 981–1030
  5. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes – review and clinical implications. Clin Chem Lab Med 2011;49:177–84
  6. Eom JE, Lee E, Jeon KH, Sim J, Suh M, Jhon GJ, et al. Development of an albumin copper binding (ACuB) assay to detect ischemia modified albumin. Anal Sci 2014;30:985–90
  7. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, et al. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 2010;95:586–91
  8. Ellidag HY, Eren E, Yilmaz N, Bayindir A. Ischemia modified albumin levels and increased oxidativestress in patients with multiple myeloma. J Med Biochem 2014;33:175–80
  9. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular event. N Engl J Med 2002;347:1557–65
  10. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A. Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Int J Obes Relat Metabol Disord 2000;24:1392–95
  11. Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011;95:1048–1058.e1–2
  12. Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, et al. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 2004;89:2160–65
  13. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil–lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008;395:27–31